Research for Patient Benefit (RfPB) Tier 3 Funding review published
Created on Tuesday, 02 May 2017.
In competition 26 RfPB introduced a high risk funding tiers (Tier 3), this report identifies what has been currently funded via tier 3. Tier 3 funds projects that are higher risk and further away from patient benefit, the report additionally looks at the pathways the studies take to achieve patient benefit.
- Tier 1 (up to £350k) for research that has a clear and close trajectory to patient benefit, such as a definitive trial.
- Tier 2 (up to £250k) for research proposals which are feasibility studies.
- Tier 3 (up to £150k) for research which is on a pathway to patient benefit yet further from it
To date 21 projects have been funded under tier 3 accounting for 22% of all RfPB funded projects.
The funded projects fall into the following research types:
- 3 systematic reviews
- 7 developing and refining interventions
- 1 meta-analysis
- 1 realist synthesis
- 1 economic evaluation
- 6 secondary data analysis (including developing predictive models and needs assessments)
- 2 diagnostic accuracy studies
Covering four types of research topics and designs:
- Therapeutic – concerned with developing and evaluating interventions to improve patient benefit
- Diagnostic – concerned with ensuring patients are appropriately classified to receive the above intervention
- Needs assessment – concerned with assessing the needs (usually of interventions) in a particular patient population
- Evidence synthesis.